Study on the relationship between serum 25-hydroxyvitamin D levels and vascular calcification in hemodialysis patients with consideration of seasonal variation in vitamin D levels

Atherosclerosis

Volumn 220, Issue 2, 2012, Pages 563-568

  Chang, Jae Hyun ^a   Ro, Han ^a   Kim, Sejoong ^b   Lee, Hyun Hee ^a   Chung, Wookyung ^a   Jung, Ji Yong ^a  

^a Gachon University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Hemodialysis; Vascular calcification; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD VESSEL CALCIFICATION; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEASONAL VARIATION; SPINE RADIOGRAPHY; SUMMER; SYSTOLIC BLOOD PRESSURE; VITAMIN D DEFICIENCY; WINTER;

ADULT; AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; RENAL DIALYSIS; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SEASONS; VASCULAR CALCIFICATION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84855963076     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.11.028     Document Type: Article

References (37)

1. Foley R.N., Parfrey P.S., Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998, 32:S112-S119.
2. Pecoits-Filho R., Lindholm B., Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant 2002, 17(Suppl. 11):28-31.
3. London G.M, Guerin A.P., Marchais S.J., et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003, 18:1731-1740.
4. Braun J., Oldendorf M., Moshage W., et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996, 27:394-401.
5. Kauppila L.I., Polak J.F., Cupples L.A., et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997, 132:245-250.
6. Blacher J., Guerin A.P., Pannier B., et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001, 38:938-942.
7. Adragao T., Pires A., Lucas C., et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 2004, 19:1480-1488.
8. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
9. Gal-Moscovici A., Sprague S.M. Use of vitamin D in chronic kidney disease patients. Kidney Int 2010, 78:146-151.
10. Forman J.P., Giovannucci E., Holmes M.D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49:1063-1069.
11. Martins D., Wolf M., Pan D., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007, 167:1159-1165.
12. Li Y.C., Kong J., Wei M., et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
13. Dusso A.S., Brown A.J., Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005, 289:F8-F28.
14. Somjen D., Weisman Y., Kohen F., et al. 25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005, 111:1666-1671.
15. Andress D.L. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 2006, 69:33-43.
16. Rajasree S., Rajpal K., Kartha C.C., et al. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol 2001, 17:567-571.
17. Zittermann A., Schleithoff S.S., Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol 2007, 18:41-46.
18. Barreto D.V., Barreto F.C., Liabeuf S., et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:1128-1135.
19. Shroff R., Egerton M., Bridel M., et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 2008, 19:1239-1246.
20. London G.M., Guerin A.P., Verbeke F.H., et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007, 18:613-620.
21. Tolouian R., Rao D.S., Goggins M., et al. Seasonal variation of vitamin D in patients on hemodialysis. Clin Nephrol 2010, 74:19-24.
22. National Kidney Foundation K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42:S1-S201.
23. Bellasi A., Ferramosca E., Muntner P., et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int 2006, 70:1623-1628.
24. Hur S.J., Kim D.M., Lim K.H., et al. Vitamin D Levels and their relationship with cardiac biomarkers in chronic hemodialysis patients. J Korean Med Sci 2009, 24:S109-S114.
25. Lee Y.M., Park S.W., Kim J.S., et al. 25-Hydroxyvitamin D status in patients with chronic kidney disease in a single center. Korean J Nephrol 2010, 29:458-464.
26. Clayton P., Singer R. 25-Hydroxyvitamin D levels in prevalent Australian dialysis patients. Nephrology (Carlton) 2009, 14:554-559.
27. Matias P.J., Ferreira C., Jorge C., et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009, 24:611-618.
28. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006, 92:4-8.
29. Melamed M.L., Michos E.D., Post W., et al. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637.
30. Mehrotra R., Kermah D.A., Salusky I.B., et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009, 76:977-983.
31. Garcia-Canton C., Bosch E., Ramirez A., et al. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant 2011, 26:2250-2256.
32. Choi H.S., Oh H.J., Choi H., et al. Vitamin D insufficiency in Korea-a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab 2011, 96:643-651.
33. Razzaque M.S. The dualistic role of vitamin D in vascular calcifications. Kidney Int 2011, 79:708-714.
34. Nakatani T., Ohnishi M., Razzaque M.S. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J 2009, 23:3702-3711.
35. Ohnishi M., Nakatani T., Lanske B., et al. Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 2009, 75:1166-1172.
36. Ohnishi M., Nakatani T., Lanske B., et al. In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin D levels. Circ Cardiovasc Genet 2009, 2:583-590.
37. Cannata-Andia J.B, Rodriguez-Garcia M., Carrillo-Lopez N., et al. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 2006, 17:S267-S273.